Related Experiment Video
Updated: May 21, 2026
05:19
Modeling Cataract Surgery in Mice
Published on: December 1, 2023
Cataract surgery in patients taking alpha-1 antagonists: know the risks, avoid the complications
Daniel M Handzel1, Sebastian Briesen, Steffen Rausch
1Dardenne Eye Hospital, Bonn, Germany. dhandzel@augenaerzte-fulda.de
Deutsches Arzteblatt International
|June 13, 2012
Summary
Intraoperative floppy iris syndrome (IFIS) complicates cataract surgery in patients taking alpha-1 receptor antagonists. Surgeon awareness of these medications is key to preventing IFIS complications during eye surgery.
Area of Science:
- Ophthalmology
- Pharmacology
Background:
- Benign prostatic hyperplasia (BPH) treatment with alpha-1 receptor antagonists can cause intraoperative floppy iris syndrome (IFIS).
- IFIS is characterized by iris billowing, poor pupillary dilation, and iris tissue protrusion during ophthalmic surgery.
- This condition poses significant challenges during cataract surgery, increasing risks of complications.
Purpose of the Study:
- To review the literature on intraoperative floppy iris syndrome (IFIS).
- To highlight the challenges and complications associated with IFIS in ophthalmic surgery.
- To emphasize the importance of physician communication in managing IFIS.
Main Methods:
- A selective review of relevant medical literature was conducted.
Main Results:
- Alpha-1 receptor antagonists affect iris alpha-receptors and induce stromal changes, leading to IFIS.
- Patient awareness of alpha-blocker use is crucial for ophthalmic surgeons to mitigate IFIS risks.
- Understanding the mechanism of IFIS is vital for surgical planning.
Conclusions:
- Comprehensive patient medical history is essential for identifying patients at risk of IFIS.
- Effective communication among urologists, family physicians, and ophthalmologists is critical for patient safety.
- Proactive management based on medication history can prevent IFIS-related complications in cataract surgery.
Related Concept Videos
01:27Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
01:28Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
01:22Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
α-Adrenergic antagonists, known as α-blockers, exert their effects by inhibiting α-adrenoceptors, leading to specific physiological actions. α1-blockers and α2-blockers have distinct pharmacological actions and therapeutic applications.
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally, α1-blockers effectively address urinary obstruction...
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally, α1-blockers effectively address urinary obstruction...
01:28Cardiac Catheterization I: Pre-Procedure Overview
Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:26Cardiac Catheterization IV: Nursing Management
Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...